Condition: Congestive Heart Failure · Sponsor: Iperboreal Pharma Srl
Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF) in patients with heart failure and reduced ejection fraction (HFrEF).
This description comes directly from the study's public registry record.
Arduino Arduini, MD · +41 79 7878312 · a.arduini@corequest.ch
Always discuss trial participation with your own doctor first.
| Ospedale Ss. Annunziata | Chieti, Italy | Recruiting |
| ASST FBF Sacco | Milan, Italy | Recruiting |
| Ospedale Monaldi | Naples, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03994874